Disease-causing mutations in the G protein β5 β-propeller disrupt its chaperonin-mediated folding trajectory

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

The Chaperonin Containing Tailless polypeptide 1 (CCT or TRiC) is an essential cytosolic chaperone that folds multiple protein substrates, including many with β-propeller folds. One β-propeller substrate is the G protein β 5 subunit (Gβ 5 ) of Regulator of G protein Signaling (RGS) complexes that determine the duration of G protein signals in neurons. In recent work, we used cryo-electron microscopy (cryo-EM) to visualize the complete CCT-mediated folding trajectory for Gβ 5 , from an initiating electrostatic interaction of a single β-strand in Gβ 5 with CCT5 to a completely folded β-propeller structure. Here, we used biochemistry and cryo-EM to determine how missense mutations in Gβ 5 , including those that cause severe neurological diseases, alter the Gβ 5 folding trajectory and lead to incompletely folded, trapped intermediates. These findings highlight how defects in chaperonin-mediated folding contribute to disease and suggest potential strategies for stabilizing misfolded proteins to restore function.

Significance

Certain missense mutations in the G protein β 5 subunit (Gβ 5 ) lead to protein misfolding and are associated with neurological disorders. Using cryo-EM, we tracked how these mutations disrupt the normal folding of Gβ 5 by the CCT chaperonin complex. Although mutant Gβ 5 still binds the complex, folding stalls mid-process, leaving the protein trapped in partially folded, non-functional states. These defects arise from disrupted side chain interactions needed to form the closed, functional structure. Our findings reveal a molecular basis for Gβ 5 misfolding in disease and suggest that pharmacological chaperones that stabilize the folded state could help restore proper function.

Article activity feed